Solutions / Due Diligence & Research / ESG Due Diligence

ESG Due Diligence

ESG diligence becomes useful when it stops producing scores and starts producing numbers a deal team can put in a model.

Priced, not ratedFindings reported with cost, timing and severity, which is what a deal team can actually model.

Below the first tierSupply chain exposure assessed past direct suppliers, with coverage stated honestly.

Regimes that will applyCurrent and forthcoming disclosure obligations, with the cost of reaching compliance.

CommercialFinancialOperational RegulatoryTechnology deal-relevantdeal-relevant materiality threshold
Findings above the materiality thresholdLogged, evidenced, below threshold

In simple terms

You tell us the asset. We assess environmental, labour, supply chain and governance exposure, and give you the cost and timing of each finding rather than a score.

What ESG Due Diligence is. ESG due diligence assesses environmental liability, labour and supply chain practice, governance quality and regulatory exposure at a target, and states the commercial and timing consequence of each finding.

What makes this different. A review that always supports the transaction is comfort, not diligence. Ours reports what it finds, including the findings that change the price or stop the deal.

What the service covers

These are the areas we work across, such as the ones below. We combine them in the proportion your question needs, and we tell you which ones your question does not need.

Environmental assessment

Site liability, permits, emissions exposure and remediation obligations, with cost and timing attached.

Social and supply chain

Labour practice, health and safety record and supply chain exposure, including tiers the target has no visibility into.

Governance review

Ownership, board effectiveness, related-party exposure and controls, assessed for real function rather than documented existence.

Regulatory exposure

Applicable and forthcoming disclosure and compliance regimes, with the cost of reaching compliance.

Questions this answers

If something like this is on your agenda, the engagement is already half scoped.

  • What environmental liability are we inheriting, and what does remediation cost?
  • What is the labour and supply chain practice below tier one?
  • Which disclosure regimes will apply to this asset, and by when?
  • Is there a governance issue that would stop our investment committee?
  • What does it cost to bring this asset to our ESG standard?

How you can use this

A few of the situations where this service does real work.

Environmental liability

A site or process may carry obligations you would inherit.

Remediation exposure with cost and timing attached

Supply chain exposure

Practices below tier one are unknown and increasingly your problem.

Exposure mapped by tier, with coverage stated

An investment committee standard

Your own policy requires assessment before approval.

A review structured to your committee's requirements

Costing the gap to standard

The asset does not meet your standard and you need the number.

The cost of bringing it up to standard, quantified

What changes for your business

The practical difference between running on this and running on what you have now, such as the following.

You price the risk instead of discovering it

Issues found in your own diligence are negotiable. Issues found in the other side's are deductions.

You spend diligence budget in the right order

A fast screen surfaces deal-stoppers before you commit to full scope on an asset that will not clear.

Committee papers stand up

Findings are evidenced, severity-rated and structured the way an investment committee expects to receive them.

You get the uncomfortable findings too

A review that only supports the deal is comfort, not diligence. Ours reports what it finds.

Valuation rests on tested assumptions

The parts of the model carrying the valuation are identified and tested separately, rather than accepted as a set.

You can act on it after close

Findings come with commercial consequence and owner, so the first hundred days start from something concrete.

Who this is for

Roles that commission this work most often include those below. Each asks a different question and gets a different cut of the same evidence.

Investors and deal teams

Does the investment case hold under independent testing?

Findings with severity, evidence and commercial consequence, in a format an investment committee accepts.

Corporate development

Are we buying what we think we are buying?

Independent assessment of market position, customers and growth assumptions, including the uncomfortable parts.

Finance and CFO teams

Are these numbers defensible?

Reconstructed and normalised financials with the estimation method stated wherever disclosure runs out.

Risk and compliance leadership

What are we inheriting that we have not priced?

Regulatory, environmental and governance exposure with cost and timing attached.

Founders and vendors preparing to sell

What will a buyer find that we have not addressed?

The issues a buyer's adviser will raise, ranked by likely price impact and whether they can still be fixed.

Typical clients

Private equity, venture and growth investorsCorporates making acquisitionsFounders and vendors preparing for an exitLenders and credit committeesAdvisory and transaction services firms

How we work

The third step is the one that makes the output usable, and it is the one most work of this kind skips.

Step 1

Understand the decision

We start from the decision the work supports: proceed, reprice, or walk. That decides what has to be proven and to what standard.

Step 2

Gather and test independently

Market, customer and financial evidence gathered directly, then tested against what management has represented.

Step 3

Read it for your position

What matters depends on your hold period, your thesis and your risk appetite. The same finding is fatal for one buyer and immaterial to another.

Step 4

Report to committee standard

Findings with severity, evidence and commercial consequence, structured the way an investment committee expects to receive them.

One finding established once Upstream supplierProducer or provider Channel or partnerInvestor Secure capability earlyBring the change forward Prepare for the shiftReprice the exposure four different recommended actions
Step three in practice. Your position decides what a finding means.

What you receive

Diligence report structured to investment committee standard

Findings register with severityevidence and commercial consequence

Financial or commercial model with scenarios

Management presentation and a live question session

Access to Phi, our AI research platformincluded

Every engagement comes with access to Phi. Ask questions of your own findings in plain language, pull the evidence behind any number, and keep querying long after the work is delivered. Your team gets the working intelligence, not just the document.

Open Phi
Request a sample Real work with the client's identity removed.

Ways to start

Tell us the decision and the date it has to be made by. We will recommend the smallest engagement that gets you there.

1-2 weeks

Red-flag review

A fast screen surfacing the issues that would stop a deal, before you spend more.

3-6 weeks

Full diligence

Complete commercial, financial or operational review to committee standard.

Ongoing

Portfolio monitoring

Continuous watch on holdings, with alerts on material change.

Common questions

Is this a ratings exercise?

No. Ratings compress incomparable things into one number. We report findings with cost, timing and severity, which is what a deal team can actually use.

How deep into the supply chain can you go?

Tier one reliably, tier two in most cases, beyond that with sampling. We state coverage rather than implying full visibility.

Who owns the work?

You do. It is exclusive to you, it is not resold, and working files are handed over unlocked.

Will you sign an NDA?

Yes, before the first conversation if you prefer.

Tell us the decision you are facing

Send us the question, the context and your timeline. You get back a recommended first step, what evidence it needs, and what it costs. Not a capability deck.